Adapthealth Corp (AHCO)vsBoston Scientific Corp (BSX)
AHCO
Adapthealth Corp
$10.79
-3.83%
HEALTHCARE · Cap: $1.49B
BSX
Boston Scientific Corp
$45.98
-0.13%
HEALTHCARE · Cap: $63.87B
Smart Verdict
WallStSmart Research — data-driven comparison
Boston Scientific Corp generates 527% more annual revenue ($20.61B vs $3.29B). BSX leads profitability with a 17.3% profit margin vs -2.4%. BSX earns a higher WallStSmart Score of 76/100 (B+).
AHCO
Hold45
out of 100
Grade: D+
BSX
Strong Buy76
out of 100
Grade: B+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+66.7%
Fair Value
$31.68
Current Price
$10.79
$20.89 discount
Margin of Safety
-23.2%
Fair Value
$37.36
Current Price
$45.98
$8.62 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Earnings expanding 100.0% YoY
Large-cap with strong market position
Growing faster than its price suggests
Reasonable price relative to book value
Strong operational efficiency at 20.6%
Areas to Watch
Smaller company, higher risk/reward
Operating margin of 0.7%
Elevated debt levels
ROE of -5.3% — below average capital efficiency
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : AHCO
The strongest argument for AHCO centers on Price/Book.
Bull Case : BSX
The strongest argument for BSX centers on EPS Growth, Market Cap, PEG Ratio. Profitability is solid with margins at 17.3% and operating margin at 20.6%. Revenue growth of 11.6% demonstrates continued momentum.
Bear Case : AHCO
The primary concerns for AHCO are Market Cap, Operating Margin, Debt/Equity.
Bear Case : BSX
The primary concerns for BSX are Altman Z-Score.
Key Dynamics to Monitor
AHCO profiles as a turnaround stock while BSX is a mature play — different risk/reward profiles.
AHCO carries more volatility with a beta of 1.45 — expect wider price swings.
BSX is growing revenue faster at 11.6% — sustainability is the question.
BSX generates stronger free cash flow (171M), providing more financial flexibility.
Bottom Line
BSX scores higher overall (76/100 vs 45/100), backed by strong 17.3% margins and 11.6% revenue growth. AHCO offers better value entry with a 66.7% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Adapthealth Corp
HEALTHCARE · MEDICAL DEVICES · USA
AdaptHealth Corp. The company is headquartered in Plymouth Meeting, Pennsylvania.
Visit Website →Boston Scientific Corp
HEALTHCARE · MEDICAL DEVICES · USA
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?